Ritalin is the most widely recognised brand name for methylphenidate hydrochloride, a central nervous system stimulant that has been a cornerstone treatment for attention deficit hyperactivity disorder (ADHD) since the 1960s. The medication is also approved in many countries for narcolepsy and, less commonly, for treatment-resistant depression or cognitive impairment in specific medical contexts. Methylphenidate […]
Attention Deficit Hyperactivity Disorder (ADHD) affects millions of Australians, both children and adults, creating significant challenges in attention, focus, and executive functioning. For many, prescription stimulant medications like Adderall and Ritalin are essential tools for managing symptoms, improving productivity, and maintaining daily routines. The rising demand for ADHD medications has pushed many patients to explore […]